Predictors of overall survival in metastatic castration-resistant prostate cancer patients receiving [(177)Lu]Lu-PSMA-617 radioligand therapy
接受[(177)Lu]Lu-PSMA-617放射性配体治疗的转移性去势抵抗性前列腺癌患者的总生存期预测因素
期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.21600
Ahmadzadehfar, Hojjat; Schlolaut, Stephan; Fimmers, Rolf; Yordanova, Anna; Hirzebruch, Stefan; Schlenkhoff, Carl; Gaertner, Florian C; Awang, Zool Hilmi; Hauser, Stefan; Essler, Markus